Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants.

Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. · 2018

Read Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. by Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6028743.txt.

Introduction

Hanlon and co-authors measure frailty in middle-aged and older adults. Their study appeared in The Lancet Public Health. It drew on 493,737 UK Biobank participants aged 37 to 73. Frailty was scored from weight loss, exhaustion, grip strength, activity level, and walking pace.

About 3 percent of participants met the frailty mark. Another 38 percent counted as pre-frail. Frailty clustered with multiple long-term conditions and deprivation. Multiple sclerosis and chronic fatigue syndrome linked to it most strongly. Frail and pre-frail people died at higher rates in nearly every age group. That held after adjusting for condition counts and lifestyle. The authors urge care to target middle-aged patients with complex needs.

Catalog record

CREATORHanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6028743

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants By Peter Hanlon, Barbara I Nicholl, Bhautesh Dinesh Jani, Duncan Lee, Ross McQueenie, Frances S Mair Published in: The Lancet. Public Health DOI: 10.1016/S2468-2667(18)30091-4 ABSTRACT Summary Background Frailty is associated with older age and multimorbidity (two or more long-term conditions); however, little is known about its prevalence or effects on mortality in younger populations. This paper aims to examine the association between frailty, multimorbidity, specific long-term conditions, and mortality in a middle-aged and older aged population. Methods Data were sourced from the UK Biobank. Frailty phenotype was based on five criteria (weight loss, exhaustion, grip strength, low physical activity, slow walking pace). Participants were deemed frail if they met at least three criteria, pre-frail if they fulfilled one or two criteria, and not frail if no criteria were met. Sociodemographic characteristics and long-term conditions were examined. The outcome was all-cause mortality, which was measured at a median of 7 years follow-up. Multinomial logistic regression compared sociodemographic characteristics and long-term conditions of frail or pre-frail participants with non-frail participants. Cox proportional hazards models examined associations between frailty or pre-frailty and mortality. Results were stratified by age group (37–45, 45–55, 55–65, 65–73 years) and sex, and were adjusted for multimorbidity count, socioeconomic status, body-mass index, smoking status, and alcohol use. Findings 493 737 participants aged 37–73 years were included in the study, of whom 16 538 (3%) were considered frail, 185 360 (38%) pre-frail, and 291 839 (59%) not frail. Frailty was significantly associated with multimorbidity (prevalence 18% [4435/25 338] in those with four or more long-term conditions; odds ratio [OR] 27·1, 95% CI 25·3–29·1) socioeconomic deprivation, smoking, obesity, and infrequent alcohol consumption. The top five long-term conditions associated with frailty were multiple sclerosis (OR 15·3; 99·75% CI 12·8–18·2); chronic fatigue syndrome (12·9; 11·1–15·0); chronic obstructive pulmonary disease (5·6; 5·2–6·1); connective tissue disease (5·4; 5·0–5·8); and diabetes (5·0; 4·7–5·2). Pre-frailty and frailty were significantly associated with mortality for all age strata in men and women (except in women aged 37–45 years) after adjustment for confounders. Interpretation Efforts to identify, manage, and prevent frailty should include middle-aged individuals with multimorbidity, in whom frailty is significantly associated with mortality, even after adjustment for number of long-term conditions, sociodemographics, and lifestyle. Research, clinical guidelines, and health-care services must shift focus from single conditions to the requirements of increasingly complex patient populations. Funding CSO Catalyst Grant and National Health Service Research for Scotland Career Research Fellowship. INTRODUCTION Multimorbidity, the presence of two or more long-term conditions, is an increasing clinical and public health challenge.1 Multimorbidity has been shown to be linked to, although not synonymous with, frailty.2 Evidence informing management of multimorbidity remains sparse with most guidelines focusing on single diseases. Both the National Institute for Health and Care Excellence (NICE) and British Geriatrics Society emphasise the importance of recognising frailty to identify patients with multimorbidity who are at greater risk of adverse outcomes and who might benefit from treatment optimisation.3, 4 The term frailty describes impaired resolution to homoeostasis following a stressor event.5 Frailty has been found to be a predictor of mortality, falls, worsening disability, hospitalisation, and care home admission in cohorts of elderly people.5 Various frailty classifications exist, but most widely cited is the frailty phenotype described by Fried and colleagues,6 which defines frailty as the presence of three or more out of five indicators: weakness (reduced grip strength), slowness (gait speed), weight loss, low physical activity, and exhaustion. People with one or two indicators are classified as pre-frail. This classification has been adapted for various epidemiological cohorts.7, 8 Fried and colleagues conceptualised frailty as a distinct clinical entity causing disability independently of clinical and subclinical disease, but frailty is widely seen as both a predictor and outcome of multimorbidity.9 Although the prevalence of multimorbidity and frailty increases with age, neither is limited to the elderly. Although most people over the age of 65 years have multimorbidity, the absolute number of people with multiple conditions is greater in people younger than age 65 years.1 Although the original description of the frailty phenotype excluded participants younger than age 65 years,6 frailty can also affect younger people.2, 10, 11 Frailty reflects biological and phenotypic, rather than chronological, age.10, 11 Precursors of frailty tend to arise earlier in the life-course.10 Implicit in the frailty phenotype is progression from pre-frailty to frailty;6 however, this progression could be reversible in some patients.12 Frailty predicts future disability but might be modifiable, particularly at an early stage,12 suggesting that identification of frailty and pre-frailty in middle age (those younger than 65 years) might have implications for prognosis, optimising care, and planning interventions, particularly in individuals with multimorbidity. Research in contextEvidence before this studyWe searched Ovid MEDLINE between January, 1996, and December, 2017, without language restriction, for articles examining the association between frailty or multimorbidity and mortality in people aged younger than 65 years. We used the following terms: “frail*”, “frail elderly”, “middle-age*”, “multimorbid*”, “multi-morbid*”, “multimorbidity”, “mortality”, “death”, and “survival”. Searches were supplemented by hand-searching reference lists of any identified systematic reviews. We also searched for articles citing the original description of the “frailty phenotype” by Fried and colleagues. We included any community-based studies with longitudinal follow-up assessing mortality that included any participants aged younger than 65 years. Thirteen cohorts were identified that included some measure of frailty and included those aged younger than 65 years (three of these used the frailty phenotype model). In all but one of these studies, the number of participants aged younger than 65 years was unclear and the mean age of the frail participants was more than 70 years. Only one study (n=998) specifically assessed the impact of frailty on mortality in those aged younger than 65 years. The phenotype model did not show a statistically significant association with mortality. No studies of the effects of multimorbidity on mortality included an assessment of frailty.Added value of this studyOur findings show a greater than two times increase in 7-year mortality that is associated with frailty (assessed using the frailty phenotype model) in a large cohort of 493 737 people aged 37–73 years. These findings are consistent across age and sex strata (except in women aged 37–45 years), and are independent of the mortality risk associated with multimorbidity. To our knowledge, this is the largest study to assess the effect of frailty on mortality to date. It also includes a greater proportion of participants aged younger than 65 years than previous studies of frailty. Previous studies have not assessed the association between the frailty phenotype and mortality adjusting for associated multimorbidity. Previous studies of frailty have also not adjusted for sociodemographics or lifestyle. Our study shows that frailty was strongly associated with socioeconomic deprivation, obesity, smoking, and multimorbidity and that the effect on mortality persisted after adjusting for these factors.Implications of all the available evidenceThe management of frailty is an important clinical priority for all health professionals, not just those caring for older people. Frailty is identifiable in middle-aged as well as older adults, and is associated with mortality independently of the extent of multimorbidity as well as age, sex, sociodemographic, and lifestyle

Read the complete text